The role of stress responses in determining cell fate following exposure to ultraviolet radiation

Radiation Protection Dosimetry

Volumn 91, Issue 1-3, 2000, Pages 81-84

  Cridland, N A ^a   Martin, M C ^a   Stevens, K ^a   Baller, C A ^a   Pearson, A J ^a   Driscoll, C M H ^a   Saunders, R D ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

CELL FATE; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; STRESS; ULTRAVIOLET C RADIATION;

EID: 0033778528     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.rpd.a033239     Document Type: Article

References (18)

1. The mammalian UV response is triggered by activation of Src tyrosine kinases
2. Fos is an essential component of the mammalian UV response
3. Protein kinase C but not tyrosine kinase promotes the survival of cultured human keratinocytes following exposure to UVR
4. Clonal growth of mammalian cells in vitro. Growth characteristics of colonies from single HeLa cells with and without a 'Feeder' layer
5. Establishment of clones of epithelial cells from human skin
6. In vitro cultivation of human tumours: Establishment of cell lines derived from a series of solid tumours
7. Measurement of colony-forming ability and mutagenesis in diploid human cells
8. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors
9. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
10. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor
11. Involvement of growth factor receptors in the mammalian UVC response
12. UV activation of receptor tyrosine kinase activity
13. UV activates growth factor receptors via reactive oxygen intermediates
14. The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase 1β (Rsk-2) and p70 S6 kinase
15. Novel indolocarbazole protein kinase C inhibitors with improved biochemical and physiochemical properties
16. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976
17. Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase C isoenzymes
18. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C